The preparation and study on properties of calcium sulfate bone cement combined tuning silk fibroin nanofibers and vancomycin‐loaded silk fibroin microspheres. Issue 3 (6th September 2021)

• Record Type: Journal Article
• Authors: Lian, Xiaojie; Xu, Rui; Liu, Shichao; Wang, Zechuan; Niu, Baolong; Huang, Di; Wei, Yan; Zhao, Liqin
• Is Part Of: Journal of biomedical materials research. Volume 110:Issue 3(2022)
• Page Start: 564
• Page End: 572
• Publication Date: 2021-09-06
• Subjects: bone cement -- calcium sulfate hemihydrate -- silk fibroin microspheres -- silk fibroin nanofibers -- vancomycin; Biomedical materials -- Periodicals; 610.28
• DOI: 10.1002/jbm.b.34935
• Languages: English
• ISSNs: 1552-4973

Abstract

Abstract: In this study, a bioactive composite material based on calcium sulfate hemihydrate (CSH) bone cement was studied, which use calcium sulfate dihydrate (CSD) as coagulant and silk fibroin nanofibers (SFF) solution as the curing liquid, further loaded vancomycin silk fibroin microspheres (SFM/VCM). The drug release effect of bone cements caused by tuning weight content of SFM/VCM (0.5, 1, 2%) and the concentration of silk fibroin solution (SFS) (20, 60, 100 mg/mL) used for preparation of SFM was studied in this article. Scanning electron microscope (SEM) demonstrated that the average diameter of microspheres gradually increased and the setting time was prolonged with the concentration of SFS increasing. X‐ray diffraction (XRD) and Fourier transform infrared (FTIR) were used to analyze the composition of composite materials. The result of compressive strength revealed that the composites contained 0.5% SFM/VCM showed better mechanical performance independent on the concentration of microspheres and the cumulative drug release percentage of all composites were less than 55% after 4 weeks. The drug‐loading bone cement possesses not only injectability but also sustained release capability which has a promising prospect in the field of bone substitute material.